Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases

Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases:

Dementia Big
Accurate diagnosis of prion diseases and discrimination from alternative dementias gain importance in the clinical routine, but partial overlap in cerebrospinal fluid (CSF) biomarkers impedes absolute discrimination in the differential diagnostic context.

http://ift.tt/2fgh7N7